• Careers
  • Contact Us
  • Media Kit
  • Home
  • Company Overview
  • Scientific Background
  • Therapeutic Focus
  • Pipeline & Intellectual Property
  • News
Refer Refer Print
  • © 2021 Oligomerix, Inc.
  • Website by Axxiem
  • Follow Us:
  • Company Overview
  • History & Mission Statement
  • Board of Directors
  • Management Team
  • Scientific Advisory Board
  • Partners & Investors
  • Scientific Background
  • Tauopathies
  • Formation of Tau Oligomers in Disease
  • Toxicity and Impairment of Memory Formation
  • Media Kit
  • Therapeutic Focus
  • Inhibitors of Tau Oligomer Formation
  • Inhibitors of Tau Oligomer Proteolytic Activity
  • Pipeline
  • Intellectual Property
  • Press Releases
  • Media Coverage
  • Scientific Publications